📌 Key Takeaways
- Topic: Fused Silica CAS 60676-86-0: Identification, Properties and Safety Data
- Keywords: pyrogenic silica
- Published: 2026-11-20 02:56:25
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Alumina Powder vs Silica Powder: Properties, Uses and How to Choose
- Silica Supply Chain: Raw Materials, Production Hubs and Risks
- Lai, C.-Y. et al. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. J. Am. Chem. Soc. 125, 4451-4459 (2003). Article CAS PubMed Google Scholar
- Silica as a Carrier: Converting Liquids into Free-Flowing Powders
- Ferrauto, G., Carniato, F., Di Gregorio, E., Botta, M. & Tei, L. Photoacoustic ratiometric assessment of mitoxantrone release from theranostic ICG-conjugated mesoporous silica nanoparticles. Nanoscale 11, 18031-18036 (2019). Article CAS PubMed Google Scholar
- Silicon Metal vs Silica: Production Process and Key Differences
- What Is TEOS? Uses in Sol-Gel Silica, Coatings and Semiconductors
Silica for Feed Carrier: How It Carries Vitamins and Liquids in Animal Feed
What is silica (SiO₂)?
silica 99% purity
What is the difference between fumed silica and precipitated silica?
spherical silica for semiconductor packaging
What drives silica raw material prices?
silica supplier Europe An additional advantage of MSNs over other inorganic NPs is their relatively superior safety profile. A typical example is that the FDA has approved colloidal silica for use as a glidant in the production of tablets. 38 Also, the widely used food additive E511 consists of amorphous silica NPs with a diameter of 100 nm. 38 Importantly, there are numbers of clinical trials and clinical studies confirming the safety and efficacy of silica NPs when used in applications such as oral drug delivery, bioimaging and PTT. For instance, in a clinical study involving 12 volunteers, ordered MSNs were able to significantly increase the bioavailability of fenofibrate by 54%, far better than the commercially available product Lipanthyl. 39 In another clinical trial involving 16 patients with prostate cancer, gold-silica nanoshells (GSNs) enabled tumor ablation by photothermal action, eventually attaining effective tumor eradication in 94% (15/16) of patients. 40 The physiological toxicity of MSNs is closely related to particle size, morphology, and structural composition. Currently, lots of silica-based nanoformulations have been developed, and their systematic safety evaluation is a matter of ongoing concern. Nonetheless, there is no doubt that mesoporous silica-based NPs will always be more promising in the biomedical field than other inorganic NPs.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.